IMNM vs TRVI: stock comparison and AI forecast
Immunome Inc. (IMNM) and Trevi Therapeutics, Inc. (TRVI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IMNM Immunome Inc.
- Price
- $18.71 -15.7% · 6M
- Market Cap
- $2.13B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
TRVI Trevi Therapeutics, Inc.
- Price
- $14.33 +2.0% · 6M
- Market Cap
- $2.04B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- IMNM and TRVI have similar market capitalizations ($2.13B and $2.04B).
- Over the last six months TRVI returned +2.0% and IMNM -15.7%.
- IMNM carries 0.08 times debt per unit of equity, against 0.03 times for TRVI.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IMNM | TRVI |
|---|---|---|
| Market Cap | $2.13B | $2.04B |
| P/B Ratio | 4.05x | 6.35x |
| EPS | $-2.58 | $-0.34 |
| Book Value/Share | $4.62 | $2.26 |
| Revenue/Share | $0.00 | – |
| FCF/Share | $-1.93 | $-0.37 |
Profitability & Margins
| Metric | IMNM | TRVI |
|---|---|---|
| ROE | -48.4% | -15.9% |
| ROA | -45.0% | -15.5% |
| ROIC | -51.1% | -18.5% |
| Tax Rate | – | 0.1% |
Financial Health
| Metric | IMNM | TRVI |
|---|---|---|
| Current Ratio | 15.08x | 37.28x |
| D/E Ratio | 0.08x | 0.03x |
| Financial Leverage | 1.08x | 1.03x |
| Interest Coverage | -15.6x | -6121.0x |
| Working Capital | $503M | $317M |
Cash Flow
| Metric | IMNM | TRVI |
|---|---|---|
| Operating Cash Flow | -$209M | -$53M |
| Free Cash Flow | -$219M | -$53M |
| Capital Spending | -$10M | -$240K |
Operational Efficiency
| Metric | IMNM | TRVI |
|---|---|---|
| Asset Turnover | 0.00x | – |
| Fixed Assets Turnover | 0.0x | – |
Income Statement
| Metric | IMNM | TRVI |
|---|---|---|
| Total Revenue | $0.00M | – |
| Operating Income | -$270M | -$60M |
| Net Income | -$254M | -$51M |
| R&D Expense | $206M | $41M |
Dividend & Shareholder Information
| Metric | IMNM | TRVI |
|---|---|---|
| Shares Outstanding | 114M | 142M |
IMNM vs TRVI: stock comparison and AI forecast
Which is bigger, IMNM or TRVI?
IMNM and TRVI have similar market capitalizations ($2.13B and $2.04B).
Which stock performed better over the last six months, IMNM or TRVI?
Over the last six months TRVI returned +2.0% and IMNM -15.7%.
Which one does Intratio's AI model rank higher, IMNM or TRVI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.